# mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer

> **NCT03365765** · PHASE3 · COMPLETED · sponsor: **Huashan Hospital** · enrollment: 63 (actual)

## Conditions studied

- Apatinib

## Interventions

- **DRUG:** Apatinib
- **DRUG:** Oxaliplatin
- **DRUG:** 5-fluorouracil

## Key facts

- **NCT ID:** NCT03365765
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-12
- **Primary completion:** 2022-12-22
- **Final completion:** 2022-12-31
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2023-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03365765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03365765, "mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03365765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*